Targeting MASLD with new nanoparticles

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Zhi-Gang She from the State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute; School of Pharmacy; First Affiliated Hospital, Gannan Medical University, Ganzhou, China. Professor She is also the Deputy Director of the Department of Cardiology, Renmin Hospital of Wuhan University. Professor She is interviewed on the paper " Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD " published in paper copy in Gut in February 2026. Please

You can listen to Targeting MASLD with new nanoparticles online on Radio and Podcast. Open the player on this page to stream the available audio.

Targeting MASLD with new nanoparticles is an episode from Gut podcast by BMJ Group.

This episode is 14:58 long.

This episode was published on Feb 2, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Gut podcast when more episodes are available from the podcast feed.